Related references
Note: Only part of the references are listed.Transformation of the intestinal epithelium by the MSI2 RNA-binding protein
Shan Wang et al.
NATURE COMMUNICATIONS (2015)
Adhesion in Mammary Development: Novel Roles for E-Cadherin in Individual and Collective Cell Migration
Eliah R. Shamir et al.
CELLULAR ADHESION IN DEVELOPMENT AND DISEASE (2015)
An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition
Chul-Yong Park et al.
CANCER LETTERS (2014)
EGFR Blockade Enriches for Lung Cancer Stem-like Cells through Notch3-Dependent Signaling
Rajeswara Rao Arasada et al.
CANCER RESEARCH (2014)
Musashi-2 controls cell fate, lineage bias, and TGF-β signaling in HSCs
Sun-Mi Park et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer
Woonyoung Choi et al.
NATURE REVIEWS UROLOGY (2014)
Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer
Tim N. Beck et al.
PHYSIOLOGICAL GENOMICS (2014)
Musashi Proteins are Post-transcriptional Regulators of the Epithelial-Luminal Cell State
Yarden Katz et al.
ELIFE (2014)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Notch1 Is Required for Kras-Induced Lung Adenocarcinoma and Controls Tumor Cell Survival via p53
Silvia Licciulli et al.
CANCER RESEARCH (2013)
Notch Pathway Activity Identifies Cells with Cancer Stem Cell-like Properties and Correlates with Worse Survival in Lung Adenocarcinoma
Khaled A. Hassan et al.
CLINICAL CANCER RESEARCH (2013)
Emerging Roles of Claudins in Human Cancer
Mi Jeong Kwon
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II
Francesco Dituri et al.
PLOS ONE (2013)
TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction
V. Tirino et al.
CELL DEATH & DISEASE (2013)
Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity
Aleix Prat et al.
SCIENTIFIC REPORTS (2013)
Suppression of SCARA5 by Snail1 is essential for EMT-associated cell migration of A549 cells
J. Liu et al.
ONCOGENESIS (2013)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Targeting the TGFβ signalling pathway in disease
Rosemary J. Akhurst et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
TGFβ signalling in context
Joan Massague
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer
Alejandra Bruna et al.
NATURE COMMUNICATIONS (2012)
Msi-1 is a Predictor of Survival and a Novel Therapeutic Target in Colon Cancer
Dawei Li et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Claudin-7 inhibits human lung cancer cell migration and invasion through ERK/MAPK signaling pathway
Zhe Lu et al.
EXPERIMENTAL CELL RESEARCH (2011)
Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs
Thordur Oskarsson et al.
NATURE MEDICINE (2011)
Safety of bevacizumab (BV) plus docetaxel (D) in patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC) who developed brain metastases during the AVADO phase III study.
LY Dirix et al.
CANCER RESEARCH (2010)
Identification of Optimal Drug Combinations Targeting Cellular Networks: Integrating Phospho-Proteomics and Computational Network Analysis
Sergio Iadevaia et al.
CANCER RESEARCH (2010)
The overexpression of the putative gut stem cell marker Musashi-1 induces tumorigenesis through Wnt and Notch activation
Amelie Rezza et al.
JOURNAL OF CELL SCIENCE (2010)
Regulation of myeloid leukaemia by the cell-fate determinant Musashi
Takahiro Ito et al.
NATURE (2010)
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia
Michael G. Kharas et al.
NATURE MEDICINE (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Reduced expression of claudin-7 is associated with poor outcome in non-small cell lung cancer
Taketsugu Yamamoto et al.
ONCOLOGY LETTERS (2010)
Functional proteomic profiling of AML predicts response and survival
Steven M. Kornblau et al.
BLOOD (2009)
Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression
Don L. Gibbons et al.
GENES & DEVELOPMENT (2009)
Up-Regulated MicroRNA-143 Transcribed by Nuclear Factor kappa B Enhances Hepatocarcinoma Metastasis by Repressing Fibronectin Expression
Xiaoying Zhang et al.
HEPATOLOGY (2009)
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
Chad J. Creighton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
Giulia Bertolini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis
Wei Liu et al.
CANCER RESEARCH (2008)
Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo
Sripathi M. Sureban et al.
GASTROENTEROLOGY (2008)
A genetic mouse model for metastatic lung cancer with gender differences in survival
S. Zheng et al.
ONCOGENE (2007)
Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells
Raoul Tibes et al.
MOLECULAR CANCER THERAPEUTICS (2006)
A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis
M Yi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
